Drug comparisons
Acetohexamide vs Ertugliflozin
Acetohexamide (sulfonylurea) boosts insulin; Ertugliflozin (SGLT2 inhibitor) increases urine glucose. Hypoglycemia vs infection/DKA risks in type 2 diabetes.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes inadequately controlled on metformin may compare an older sulfonylurea like Acetohexamide against a newer SGLT2 inhibitor like Ertugliflozin.
Bottom line
Acetohexamide and Ertugliflozin both lower blood glucose in type 2 diabetes but neither is universally superior; selection depends on patient-specific factors and risks.
All medication comparisons